"Patents as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about exclusive legal rights or privileges applied to inventions, plants, etc.
Descriptor ID |
D010330
|
MeSH Number(s) |
I01.880.604.583.458.650 N03.706.535.518.650
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Patents as Topic".
Below are MeSH descriptors whose meaning is more specific than "Patents as Topic".
This graph shows the total number of publications written about "Patents as Topic" by people in this website by year, and whether "Patents as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 1 | 2 |
2008 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2017 | 6 | 15 | 21 |
2018 | 8 | 11 | 19 |
2019 | 4 | 9 | 13 |
2020 | 1 | 0 | 1 |
2021 | 1 | 4 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Patents as Topic" by people in Profiles.
-
Information Disclosed in Patent Documents being the Source to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19. Recent Pat Biotechnol. 2021 Oct 04; 15(2):148-163.
-
Chelsea Clinton urges global sharing of COVID vaccine technology. Nature. 2021 08; 596(7872):331.
-
Inhibitory activities of bipyrazoles: a patent review. Expert Opin Ther Pat. 2022 Jan; 32(1):63-87.
-
The patent maze of COVID 19 vaccines. Expert Opin Ther Pat. 2021 Dec; 31(12):1177-1188.
-
Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic. JAMA. 2021 Jul 20; 326(3):219-220.
-
[Access to anti-covid vaccines: research, development and role of patents.] Recenti Prog Med. 2021 Jul-Aug; 112(7):499-503.
-
Information Opacity in Biopharmaceutical Innovation Through the Lens of COVID-19. Am J Law Med. 2021 07; 47(2-3):157-175.
-
The COVID vaccine pioneer behind southeast Asia's first mRNA shot. Nature. 2021 06; 594(7862):163.
-
What next for a COVID-19 intellectual property waiver? Lancet. 2021 05 22; 397(10288):1871-1872.
-
siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses. Mol Pharm. 2021 06 07; 18(6):2105-2121.